Denmark and Kim
685
6.91 (m, 2 H), 4.08 (ddd, J = 11.7, 4.7, 2.6, 1 H), 3.69 (dd,
J = 11.9,3.1, 1 H), 3.51 (dq, J = 20.3, 7.3, 1 H), 2.78 (d, J =
7.8, 3 H), 2.45(d, J = 8.9, 1 H), 1.77 (dd, J = 17.1, 7.4, 3 H),
1.59 (m, 1 H), 1.47 (ddd, J = 14.3, 12.0, 4.8, 1 H). 13C NMR
(75.5 MHz): 141.56 (JCP = 6.5), 140.43 (JCP = 6.7), 140.35,
128.77, 128.69, 128.62, 128.12, 128.08, 128.04, 127.22,
127.14, 126.91, 126.64, 126.59, 126.53, 61.16, 59.12, 44.16
(JCP = 121.3), 40.86 (JCP = 3.3), 34.45 (JCP = 4.4), 33.99
(JCP = 1.7), 15.80 (JCP = 4.2). 31P NMR (121.6 MHz): 31.80.
MS (70 eV): 300 (M+ +1 – PhC2H4, 20), 626 (M+ – PhC2H4,
100). Anal. calcd. for C25H29N2OP (404.49): C 74.24, H
7.23, N 6.93, P 7.66; found: C 74.31, H 7.26, N 6.94, P
7.76. Data for 8a′: TLC: Rf = 0.42 (hexane/EtOAc/i-PrOH,
ple was obtained by recrystallization from pentane/Et2O: mp
114–117°C. IR (CCl4): 2904 s, 1252 s. TLC: Rf 0.41 (hex-
ane/EtOAc/i-PrOH, 35:60:5). HPLC: tR = 7.30 min (42%),
8.57 min (58%), Supelco LC-NH2, (hexane/EtOAc, 3:2),
flow rate = 1.0 mL/min). 1H NMR (CDCl3, 300 MHz):
7.48–7.17 (m, 15 H), 4.55 (dt, J = 13.1, 3.7, 0.4 H), 4.46 (dt,
J = 9.9, 3.8, 0.6 H), 4.14 (dt, J = 12.4, 3.0, 0.6 H), 4.04–3.77
(m, 1 H), 3.69–3.26 (m, 1.4 H), 2.62–2.52 (m, 0.6 H), 2.33–
2.23 (m, 0.4 H), 1.98–1.80 (m, 1 H), 1.82 (dd, J = 17.5, 7.2,
1.8 H), 1.74 (dd, J = 17.4, 7.3, 1.2 H), 1.29 (d, J = 6.8, 1.8
H) 1.22 (d, J = 6.7, 1.2 H), 1.16 (d, J = 6.9, 1.2 H), 0.96 (d,
J = 6.8 1.8 H), 0.86 (d, J = 6.6, 1.2 H), 0.72 (d, J = 6.7, 1.8
H), 0.54 (d, J = 6.8, 1.2 H), 0.48 (d, J = 6.7, 1.8 H). 13C
NMR (75.5 MHz): 145.30 (JCP = 3.8), 144.33 (JCP = 4.7),
143.47, 143.43, 141.50 (JCP = 5.2), 141.12 (JCP = 4.8),
129.25, 129.17, 129.06, 128.98, 128.42, 128.21, 128.19,
128.00, 127.97, 127.93, 127.91, 127.83, 127.26, 127.11,
127.07, 127.03, 126.95, 126.84, 126.49, 126.45, 126.30,
126.28, 55.20, 54.97, 54.47 (JCP = 1.9), 54.25, 49.35, 48.57
(JCP = 117.6), 47.54 (JCP = 3.4), 47.01 (JCP = 4.3), 46.85
(JCP = 119.6), 43.10 (JCP = 6.2), 43.00, 25.15, 24.74, 23.12
1
35:62:3). H NMR (300 MHz): 7.51–7.09 (m, 15 H), 4.26
(dt, J = 11.3, 3.5, 1 H), 3.77 (dd, J = 12.2, 1.5, 1 H), 3.35
(dq, J = 17.8, 7.2, 1 H), 2.59 (d, J = 8.4, 3 H), 2.45 (m, 1 H),
2.07 (d, J = 7.4, 3 H), 2.03 (m, 1 H), 1.77 (dd, J = 117.6,
7.2, 3 H). 31P NMR (121.6 MHz): 29.82. MS (70 eV): 313
(14), 300 (M+ + 1 – PhC2H4, 20), 626 (M+ – PhC2H4, 100).
(RS)-(4l,6l,1′x)-1,3-Diethyl-4,6-diphenyl-2-(1-phenylethyl)-
1,3,2-diaza-phosphorinane 2-oxide (8b): From 98 mg
(0.23 mmol) of 5b, 138 µL (0.23 mmol) of n-BuLi (1.70 M),
and 44 µL (0.71 mmol) of methyl iodide followed by purifi-
cation by SiO2 column chromatography (hexane/EtOAc/i-
PrOH, 31:62:7) was obtained 80 mg (78%) of a 61:39
(HPLC) diastereomeric mixture of 8b as a sticky oil and
14.3 mg (13%) of recovered 5b. An analytical sample was
obtained by recrystallization from pentane/Et2O at –78°C:
mp 49–53°C. IR (CCl4): 3029 w, 1239 s. TLC: Rf 0.44 (mi-
nor), 0.34 (major) (hexane/EtOAc/i-PrOH, 31:62:7). HPLC:
tR = 7.25 min (39%), 8.37 min (61%), (Supelco LC-NH2,
(JCP = 3.3), 21.91 (JCP = 2.6), 21.89, 21.36, 20.22 (JCP
=
4.2), 18.71 (JCP = 3.4), 18.27 (JCP = 4.1), 18.06 (JCP = 3.4).
31P NMR (121.6 MHz): 29.16 (major), 28.13 (minor). MS
(70 eV): 445 (M+ – CH3), 355 (100). Anal. calcd. for
C29H37N2OP (460.60): C 75.62, H 8.10, N 6.08, P 6.72;
found: C 75.42, H 8.17, N, 5.99, P 6.74.
(RS)-(4l,6l,1′x)-1,3-Bis-(2,2-dimethylpropyl)-4,6-diphenyl-2-
(1-phenylethyl)-1,3,2-diazaphosphorinane 2-oxide (8d): From
180 mg (0.36 mmol) of 5d, 211 µL (0.36 mmol) of n-BuLi
(1.70 M), and 67 µL (1.07 mmol) of methyl iodide followed
by purification by SiO2 column chromatography (hex-
ane/EtOAc, 2:1) was obtained 152 mg (82%) of a 92:8 (31P
NMR) diastereomeric mixture of 8d as a foam and 19.5 mg
(11%) of recovered 5d. An analytical sample was obtained
by recrystallization from TBME. Enantiomerically enriched
(–)-8d was also prepared from (S,S)-5d in 74% yield with
94:6 ratio of diastereomers: mp 150–152°C. For (–)-8d:
[α] = – 98.4 (c = 1.04, CHCl3), [α] = – 281.5 (c = 1.04,
CHCl3). IR (CCl4): 3065 w, 1244 s. TLC: Rf 0.54 (hex-
ane/EtOAc, 2:1). HPLC: tR = 8.30 min (92%), 9.62 min
(8%), (Supelco LC-NH2, (hexane/EtOAc, 85:15), flow rate =
1
(hexane/EtOAc, 30:70), flow rate = 1.0 mL/min). H NMR
(300 MHz): 7.57–7.08 (m, 15 H), 4.50–4.45 (m, 1H), 4.02–
3.95 (m, 1 H), 3.53–3.19 (m, 2.6 H), 3.04–2.90 (m, 1 H),
2.64–2.52 (m, 1 H), 2.42 (ddd, J = 14.0, 10.2, 4.1, 0.4 H),
2.31 (dheptet, J = 9.2, 6.9, 0.4 H), 2.07 (dt, J = 14.6, 3.1, 0.4 H),
1.95 (ddd, J = 16.8, 14.2, 4.3, 0.6 H), 1.83–1.78 (m, 0.6 H),
1.77 (dd, J = 9.6, 7.4, 1.8 H), 1.74 (dd, J = 10.0, 7.3, 1.2 H),
1.08 (t, J = 7.1, 1.8 H), 1.03 (t, J = 7.0, 1.2 H), 0.96 (t, J =
6.9, 1.8 H), 0.44 (t, J = 7.1, 1.2 H). 13C NMR (75.5 MHz):
142.20 (JCP = 4.8), 141.38 (JCP = 5.3), 140.94 (JCP = 5.7),
140.81 (JCP = 6.2), 140.31, 140.05, 129.03, 128.99, 128.59,
128.44, 128.39, 128.29, 128.12, 128.06, 127.42, 127.38,
127.22, 127.20, 127.10, 126.99, 126.92, 126.67, 126.60,
1
1.0 mL/min). H NMR (300 MHz): 7.60–7.14 (m, 15 H),
4.65–4.58 (m, 0.08 H), 4.39–4.33 (m, 1.84 H), 4.24–4.17
(m, 0.08 H), 3.46 (dq, J = 14.3, 7.3, 1 H), 3.29 (dd, J = 14.6,
8.0, 0.92 H), 3.22 (dd, J = 14.8, 8.4, 0.08 H), 3.12 (dd, J =
14.8, 5.9, 0.08 H), 2.96 (dd, J = 15.2, 8.5, 0.08 H), 2.73
(ddd, J = 16.5, 12.9, 4.2, 0.92 H), 2.55–2.44 (m, 1.92 H),
2.34–2.21 (m, 0.08 H), 2.15–1.93 (m, 2 H), 1.77 (dd, J =
17.6, 7.2, 0.24 H), 1.75 (dd, J = 16.8, 7.2, 2.76 H). 13C NMR
(75.5 MHz): 142.07, 141.86 (JCP = 5.5), 141.67, 129.38,
129.29, 129.06, 128.99, 128.66, 128.28, 128.03, 127.62,
127.41, 127.33, 127.19, 127.10, 127.01, 126.85, 126.57,
126.54, 126.42, 63.44, 61.36 (JCP = 1.7), 60.89, 58.75,
126.58, 126.46, 57.87, 57.41, 55.05, 54.18, 48.46 (JCP
121.7), 45.86 (JCP = 122.0), 41.61 (JCP = 5.8), 41.27 (JCP
4.2), 39.93 (JCP = 2.9), 39.85, 39.81, 39.64, 17.63 (JCP
3.2), 17.26 (JCP = 3.7), 13.59, 13.33 (JCP = 3.7), 13.28,
12.20 (JCP = 3.6). 31P NMR (121.6 MHz): 29.34 (major),
28.76 (minor). MS (70 eV): 328 (M+ +1 – PhC2H4, 22), 327
(M+ – PhC2H4, 100). Anal. calcd. for C27H33N2OP (432.54):
C 74.97, H 7.69, N 6.48, P 7.16; found: C 74.88, H 7.87, N
6.36, P 6.94.
=
=
=
(RS)-(4l,6l,1′x)-1,3-Bis(1-methylethyl)-4,6-diphenyl-2-(1-phenyl-
ethyl)-1,3,2-diazaphosphorinane 2-oxide (8c): From 170 mg
(0.38 mmol) of 5c, 224 µL (0.38 mmol) of n-BuLi (1.70 M),
and 71 µL (1.14 mmol) of methyl iodide followed by purifi-
cation by column chromatography (hexane/EtOAc/i-PrOH,
35:60:5) was obtained 153 mg (87%) of a 58:42 (31P NMR)
diastereomeric mixture of 8c as a foam. An analytical sam-
57.98, 57.70 (JCP = 2.7), 56.11 (JCP = 1.9), 55.19 (JCP
2.2), 49.64 (JCP = 109.5), 47.11 (JCP = 110.0), 42.78 (JCP
=
=
9.5), 42.49 (JCP = 7.2), 34.27, 33.52, 32.46 (JCP = 3.7),
31.68 (JCP = 3.2), 29.34, 29.23, 29.09, 28.27, 20.19 (JCP
=
4.9), 18.66 (JCP = 4.2). 31P NMR (121.6 MHz): 29.55 (mi-
nor), 28.47 (major). MS (70 eV): 501 (M+ – CH3, 2.2), 411
© 2000 NRC Canada